About
Voyager Acquisition Corp (NASDAQ:VACH) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 13 2026
Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG
Mar 11 2026
Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG
Jul 17 2025
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
May 29 2025
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
May 20 2025
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
Financials
Revenue
$0
Market Cap
$401.95 M
P/E Ratio
45.39
EPS
0.28
Translate